Screening for clonal hematopoiesis as a predictive marker for development of therapy-related myeloid neoplasia (t-MN) following neoadjuvant therapy for breast cancer: a Southwest Oncology Group study (S0012).

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples